{% extends "base.html" %}
{% block title %}List of Morphology{% endblock %}
{% block head %}
{{ super() }}
<script type="text/javascript">
    active_menu = 'help';
    active_submenu = '';
</script>
{% endblock %}

{% block content %}
<main>
    <div class="page-banner">
        <div class="container">
            <h1 class="fw-bold p-2 my-0">List of Morphologies</h1>
        </div>
    </div>
    <div class="container">
        <div class="p-2 my-3">
            <p>Tumor types are classified according to the
                International Classification of Diseases <br/>
                for Oncology (<a href="https://training.seer.cancer.gov/icdo3/" target="_blank"
                                 rel="noopener noreferrer">ICD-O</a>),
                3rd Edition, World Health Organization, Geneva, 2000.
            </p>
            <table class="table table-striped table-sm">
                <thead>
                <tr>
                    <th>Morpho_code</th>
                    <th>Morphology</th>
                    <th>Code_source</th>
                    <th>Morphogroup</th>
                </tr>
                </thead>
                <tbody>
                <tr>
                    <td>1</td>
                    <td>Normal tissue</td>
                    <td>Other</td>
                    <td>NORMAL TISSUE</td>
                </tr>
                <tr>
                    <td>2</td>
                    <td>Embryo fibroblasts</td>
                    <td>Other</td>
                    <td>NORMAL TISSUE</td>
                </tr>
                <tr>
                    <td>3</td>
                    <td>Pterygium</td>
                    <td>Other</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>30100</td>
                    <td>Esophagitis</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>4</td>
                    <td>Pulmonary sclerosing hemangioma</td>
                    <td>Other</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>49000</td>
                    <td>Fibrosis, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>49720</td>
                    <td>Keloid</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>5</td>
                    <td>Plasmacytoid carcinoma</td>
                    <td>Other</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72000</td>
                    <td>Hyperplasia, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72040</td>
                    <td>Polyp, hyperplastic</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72420</td>
                    <td>Hyperplasia, glandular</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72600</td>
                    <td>Keratosis, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72830</td>
                    <td>Leucoplakia, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72850</td>
                    <td>Keratosis, actinic</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>72860</td>
                    <td>Keratoacanthoma, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>73000</td>
                    <td>Metaplasia</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>73330</td>
                    <td>Barrett's esophagus</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>74000</td>
                    <td>Dysplasia, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>74006</td>
                    <td>Dysplasia, mild</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>74007</td>
                    <td>Dysplasia, moderate</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>74008</td>
                    <td>Dysplasia, severe</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>74840</td>
                    <td>Von Recklinghausen disease, bone</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>76500</td>
                    <td>Endometriosis, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>76800</td>
                    <td>Polyp, NOS</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>76820</td>
                    <td>Inflammatory pseudotumor</td>
                    <td>SNOMED</td>
                    <td>OTHER LESIONS</td>
                </tr>
                <tr>
                    <td>8000/0</td>
                    <td>Neoplasm, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8000/1</td>
                    <td>Neoplasm, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8000/3</td>
                    <td>Cancer, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8000/6</td>
                    <td>Tumor, metastatic</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8000/9</td>
                    <td>Neoplasm, malignant, uncertain whether primary or metastatic</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8001/0</td>
                    <td>Tumor cells, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8001/1</td>
                    <td>Tumor cells, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8001/3</td>
                    <td>Tumor cells, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8002/3</td>
                    <td>Malignant tumor, small cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8003/3</td>
                    <td>Malignant tumor, giant cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8004/3</td>
                    <td>Malignant tumor, spindle cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8005/0</td>
                    <td>Clear cell tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8005/3</td>
                    <td>Malignant tumor, clear cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8010/0</td>
                    <td>Epithelial tumor, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8010/2</td>
                    <td>Carcinoma in situ, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8010/3</td>
                    <td>Carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8010/6</td>
                    <td>Carcinoma, metastatic, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8010/9</td>
                    <td>Carcinomatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8011/0</td>
                    <td>Epithelioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8011/3</td>
                    <td>Epithelioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8012/3</td>
                    <td>Large cell carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8013/3</td>
                    <td>Large cell neuroendocrine carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8014/3</td>
                    <td>Large cell carcinoma with rhabdoid phenotype</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8015/3</td>
                    <td>Glassy cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8020/3</td>
                    <td>Carcinoma, undifferentiated, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8021/3</td>
                    <td>Carcinoma, anaplastic, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8022/3</td>
                    <td>Pleomorphic carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8030/3</td>
                    <td>Giant cell and spindle cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8031/3</td>
                    <td>Giant cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8032/3</td>
                    <td>Spindle cell carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8033/3</td>
                    <td>Pseudosarcomatous carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8034/3</td>
                    <td>Polygonal cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8035/3</td>
                    <td>Carcinoma with osteoclast-like giant cells</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8040/0</td>
                    <td>Tumorlet, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8040/1</td>
                    <td>Tumorlet, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8041/3</td>
                    <td>Small cell carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8042/3</td>
                    <td>Oat cell carcinoma (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8043/3</td>
                    <td>Small cell carcinoma, fusiform cell</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8044/3</td>
                    <td>Small cell carcinoma, intermediate cell</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8045/3</td>
                    <td>Combined small cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8046/3</td>
                    <td>Non-small cell carcinoma (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>EPITHELIAL NEOPLASMS, NOS</td>
                </tr>
                <tr>
                    <td>8050/0</td>
                    <td>Papilloma, NOS (except Papilloma of bladder M-8120/1)</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8050/2</td>
                    <td>Papillary carcinoma in situ</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8050/3</td>
                    <td>Papillary carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8051/0</td>
                    <td>Verrucous papilloma</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8051/3</td>
                    <td>Verrucous carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8052/0</td>
                    <td>Squamous cell papilloma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8052/2</td>
                    <td>Papillary squamous cell carcinoma, non-invasive</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8052/3</td>
                    <td>Papillary squamous cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8053/0</td>
                    <td>Squamous cell papilloma, inverted</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8060/0</td>
                    <td>Squamous papillomatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8070/2</td>
                    <td>Squamous cell carcinoma in situ, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8070/3</td>
                    <td>Squamous cell carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8070/6</td>
                    <td>Squamous cell carcinoma, metastatic, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8071/3</td>
                    <td>Squamous cell carcinoma, keratinizing, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8072/3</td>
                    <td>Squamous cell carcinoma, large cell, nonkeratinizing, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8073/3</td>
                    <td>Squamous cell carcinoma, small cell, nonkeratinizing</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8074/3</td>
                    <td>Squamous cell carcinoma, spindle cell</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8075/3</td>
                    <td>Squamous cell carcinoma, adeno√Ød</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8076/2</td>
                    <td>Squamous cell carcinoma in situ with questionable stromal invasion</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8076/3</td>
                    <td>Squamous cell carcinoma, microinvasive</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8077/2</td>
                    <td>Squamous intraepithelial neoplasia, grade III</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8078/3</td>
                    <td>Squamous cell carcinoma with horn formation</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8080/2</td>
                    <td>Queyrat erythroplasia (C60._)</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8081/2</td>
                    <td>Bowen disease (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8082/3</td>
                    <td>Lymphoepithelial carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8083/3</td>
                    <td>Basaloid squamous cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8084/3</td>
                    <td>Squamous cell carcinoma, clear cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>SQUAMOUS CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8090/1</td>
                    <td>Basal cell tumor (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8090/3</td>
                    <td>Basal cell carcinoma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8091/3</td>
                    <td>Multifocal superficial basal cell carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8092/3</td>
                    <td>Infiltrating basal cell carcinoma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8093/3</td>
                    <td>Basal cell carcinoma, fibroepithelial (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8094/3</td>
                    <td>Basosquamous carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8095/3</td>
                    <td>Metatypical carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8096/0</td>
                    <td>Intraepidermal epithelioma of Jadassohn (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8097/3</td>
                    <td>Basal cell carcinoma, nodular (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8098/3</td>
                    <td>Adenoid basal carcinoma (C53._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8100/0</td>
                    <td>Trichoepithelioma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8101/0</td>
                    <td>Trichofolliculoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8102/0</td>
                    <td>Trichilemmoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8102/3</td>
                    <td>Trichilemmocarcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8103/0</td>
                    <td>Pilar tumor (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8110/0</td>
                    <td>Pilomatrixoma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8110/3</td>
                    <td>Pilomatrix carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>BASAL CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8120/0</td>
                    <td>Transitional cell papilloma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8120/1</td>
                    <td>Urothelial papilloma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8120/2</td>
                    <td>Transitional cell carcinoma in situ</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8120/3</td>
                    <td>Transitional cell carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8121/0</td>
                    <td>Schneiderian papilloma, NOS (C30.0, C31._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8121/1</td>
                    <td>Transitional cell papilloma, inverted, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8121/3</td>
                    <td>Schneiderian carcinoma (C30.0, C31._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8122/3</td>
                    <td>Transitional cell carcinoma, spindle cell</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8123/3</td>
                    <td>Basaloid carcinoma (C21.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8124/3</td>
                    <td>Cloacogenic carcinoma (C21.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8130/1</td>
                    <td>Papillary transitional cell neoplasm of low malignant potential (C67._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8130/2</td>
                    <td>Papillary transitional cell carcinoma, non invasive (C67._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8130/3</td>
                    <td>Papillary transitional cell carcinoma (C67._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8131/3</td>
                    <td>Transitional cell carcinoma, micropapillary (C67._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TRANSITIONAL CELL PAPILLOMAS AND CARCINOMAS</td>
                </tr>
                <tr>
                    <td>8140/0</td>
                    <td>Adenoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8140/1</td>
                    <td>Atypical adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8140/2</td>
                    <td>Adenocarcinoma in situ, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8140/3</td>
                    <td>Adenocarcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8140/6</td>
                    <td>Adenocarcinoma, metastatic, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8141/3</td>
                    <td>Scirrhous adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8142/3</td>
                    <td>Linitis plastica (C16._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8143/3</td>
                    <td>Superficial spreading adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8144/3</td>
                    <td>Adenocarcinoma, intestinal type (C16._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8145/3</td>
                    <td>Adenocarcinoma, diffuse type (C16._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8146/0</td>
                    <td>Monomorphic adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8147/0</td>
                    <td>Basal cell adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8147/3</td>
                    <td>Basal cell adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8148/2</td>
                    <td>Glandular intraepithelial neoplasia, grade III</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8149/0</td>
                    <td>Canalicular adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8150/0</td>
                    <td>Islet cell adenoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8150/1</td>
                    <td>Islet cell tumor, NOS (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8150/3</td>
                    <td>Islet cell carcinoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8151/0</td>
                    <td>Insulinoma, NOS (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8151/3</td>
                    <td>Insulinoma, malignant (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8152/1</td>
                    <td>Glucagonoma, NOS (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8152/3</td>
                    <td>Glucagonoma, malignant (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8153/1</td>
                    <td>Gastrinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8153/3</td>
                    <td>Gastrinoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8154/3</td>
                    <td>Mixed islet cell and exocrine adenocarcinoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8155/1</td>
                    <td>Vipoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8155/3</td>
                    <td>Vipoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8156/1</td>
                    <td>Somatostatinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8156/3</td>
                    <td>Somatostatinoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8157/1</td>
                    <td>Enteroglucagonoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8157/3</td>
                    <td>Enteroglucagonoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8160/0</td>
                    <td>Bile duct adenoma (C22.1, C24.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8160/3</td>
                    <td>Cholangiocarcinoma (C22.1, C24.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8161/0</td>
                    <td>Bile duct cystadenoma (C22.1, C24.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8161/3</td>
                    <td>Bile duct cystadenocarcinoma (C22.1, C24.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8162/3</td>
                    <td>Klatskin tumor (C22.1, C24.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8170/0</td>
                    <td>Hepatocellular adenoma (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8170/3</td>
                    <td>Hepatocellular carcinoma, NOS (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8171/3</td>
                    <td>Hepatocellular carcinoma, fibrolamellar (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8172/3</td>
                    <td>Hepatocellular carcinoma, scirrhous (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8173/3</td>
                    <td>Hepatocellular carcinoma, spindle cell variant (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8174/3</td>
                    <td>Hepatocellular carcinoma, clear cell type (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8175/3</td>
                    <td>Hepatocellular carcinoma, pleomorphic type (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8180/3</td>
                    <td>Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8190/0</td>
                    <td>Trabecular adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8190/3</td>
                    <td>Trabecular adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8191/0</td>
                    <td>Embryonal adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8200/0</td>
                    <td>Eccrine dermal cylindroma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8200/3</td>
                    <td>Adenoid cystic carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8201/2</td>
                    <td>Cribriform carcinoma in situ (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8201/3</td>
                    <td>Cribriform carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8202/0</td>
                    <td>Microcystic adenoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8204/0</td>
                    <td>Lactating adenoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8210/0</td>
                    <td>Adenomatous polyp, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8210/2</td>
                    <td>Adenocarcinoma in situ in adenomatous polyp</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8210/3</td>
                    <td>Adenocarcinoma in adenomatous polyp</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8211/0</td>
                    <td>Tubular adenoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8211/3</td>
                    <td>Tubular adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8212/0</td>
                    <td>Flat adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8213/0</td>
                    <td>Serrated adenoma (C18._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8214/3</td>
                    <td>Parietal cell carcinoma (C16._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8215/3</td>
                    <td>Adenocarcinoma of anal glands (C21.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8220/0</td>
                    <td>Adenomatous polyposis coli (C18._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8220/3</td>
                    <td>Adenocarcinoma in adenomatous polyposis coli (C18._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8221/0</td>
                    <td>Multiple adenomatous polyps</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8221/3</td>
                    <td>Adenocarcinoma in multiple adenomatous polyps</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8230/2</td>
                    <td>Ductal carcinoma in situ, solid type (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8230/3</td>
                    <td>Solid carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8231/3</td>
                    <td>Carcinoma simplex</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8240/1</td>
                    <td>Carcinoid tumor of uncertain malignant potential</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8240/3</td>
                    <td>Carcinoid tumor, NOS (except of Appendix M-8240/1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8241/3</td>
                    <td>Carcinoid tumor, argentaffin, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8242/1</td>
                    <td>Enterochromaffin-like cell carcinoid, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8243/3</td>
                    <td>Goblet cell carcinoid</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8244/3</td>
                    <td>Composite carcinoid</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8245/1</td>
                    <td>Tubular carcinoid</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8245/3</td>
                    <td>Adenocarcinoid tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8246/3</td>
                    <td>Neuroendocrine carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8247/3</td>
                    <td>Merkel cell carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8248/1</td>
                    <td>Apudoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8249/3</td>
                    <td>Atypical carcinoid tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8250/1</td>
                    <td>Pulmonary adenomatosis (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8250/3</td>
                    <td>Bronchiolo-alveolar adenocarcinoma (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8251/0</td>
                    <td>Alveolar adenoma (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8251/3</td>
                    <td>Alveolar adenocarcinoma (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8252/3</td>
                    <td>Bronchiolo-alveolar carcinoma, non mucinous (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8253/3</td>
                    <td>Bronchiolo-alveolar carcinoma, mucinous (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8254/3</td>
                    <td>Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous(C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8255/3</td>
                    <td>Adenocarcinoma with mixed subtypes</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8260/0</td>
                    <td>Papillary adenoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8260/3</td>
                    <td>Papillary adenocarcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8261/0</td>
                    <td>Villous adenoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8261/2</td>
                    <td>Adenocarcinoma in situ in villous adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8261/3</td>
                    <td>Adenocarcinoma in villous adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8262/3</td>
                    <td>Villous adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8263/0</td>
                    <td>Tubulovillous adenoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8263/2</td>
                    <td>Adenocarcinoma in situ in tubulovillous adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8263/3</td>
                    <td>Adenocarcinoma in tubulovillous adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8264/0</td>
                    <td>Papillomatosis, glandular</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8270/0</td>
                    <td>Chromophobe adenoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8270/3</td>
                    <td>Chromophobe carcinoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8271/0</td>
                    <td>Prolactinoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8272/0</td>
                    <td>Pituitary adenoma, NOS (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8272/3</td>
                    <td>Pituitary carcinoma, NOS (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8280/0</td>
                    <td>Acidophil adenoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8280/3</td>
                    <td>Acidophil carcinoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8281/0</td>
                    <td>Mixed acidophil-basophil adenoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8281/3</td>
                    <td>Mixed acidophil-basophil carcinoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8290/0</td>
                    <td>Oxyphilic adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8290/3</td>
                    <td>Oxyphilic adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8300/0</td>
                    <td>Basophil adenoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8300/3</td>
                    <td>Basophil carcinoma (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8310/0</td>
                    <td>Clear cell adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8310/3</td>
                    <td>Clear cell adenocarcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8311/1</td>
                    <td>Hypernephroid tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8312/3</td>
                    <td>Renal cell carcinoma, NOS (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8313/0</td>
                    <td>Clear cell adenofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8313/1</td>
                    <td>Clear cell adenofibroma of borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8313/3</td>
                    <td>Clear cell adenocarcinofibroma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8314/3</td>
                    <td>Lipid-rich carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8315/3</td>
                    <td>Glycogen-rich carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8316/3</td>
                    <td>Cyst-associated renal cell carcinoma (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8317/3</td>
                    <td>Renal cell carcinoma, chromophobe type (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8318/3</td>
                    <td>Renal cell carcinoma, sarcomatoid (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8319/3</td>
                    <td>Collecting duct carcinoma (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8320/3</td>
                    <td>Granular cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8321/0</td>
                    <td>Chief cell adenoma (C75.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8322/0</td>
                    <td>Water-clear cell adenoma (C75.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8322/3</td>
                    <td>Water-clear cell adenocarcinoma (C75.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8323/0</td>
                    <td>Mixed cell adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8323/3</td>
                    <td>Mixed cell adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8324/0</td>
                    <td>Lipoadenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8325/0</td>
                    <td>Metanephric adenoma (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8330/0</td>
                    <td>Follicular adenoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8330/1</td>
                    <td>Atypical follicular adenoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8330/3</td>
                    <td>Follicular adenocarcinoma, NOS (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8331/3</td>
                    <td>Follicular adenocarcinoma, well differentiated (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8332/3</td>
                    <td>Follicular adenocarcinoma, trabecular (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8333/0</td>
                    <td>Microfollicular adenoma, NOS (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8333/3</td>
                    <td>Fetal adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8334/0</td>
                    <td>Macrofollicular adenoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8335/3</td>
                    <td>Follicular carcinoma, minimally invasisve (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8336/0</td>
                    <td>Hyalinizing trabecular adenoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8337/3</td>
                    <td>Insular carcinoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8340/3</td>
                    <td>Papillary carcinoma, follicular variant (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8341/3</td>
                    <td>Papillary microcarcinoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8342/3</td>
                    <td>Papillary carcinoma, oxyphilic cell (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8343/3</td>
                    <td>Papillary carcinoma, encapsulated (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8344/3</td>
                    <td>Papillary carcinoma, columnar cell (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8345/3</td>
                    <td>Medullary carcinoma with amyloid stroma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8346/3</td>
                    <td>Mixed medullary-follicular carcinoma (C 73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8347/3</td>
                    <td>Mixed medullary-paillary carcinoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8350/3</td>
                    <td>Nonencapsulated sclerosing carcinoma (C73.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8360/1</td>
                    <td>Multiple endocrine adenomas</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8361/0</td>
                    <td>Juxtaglomerular tumor (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8370/0</td>
                    <td>Adrenal cortical adenoma, NOS (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8370/3</td>
                    <td>Adrenal cortical carcinoma (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8371/0</td>
                    <td>Adrenal cortical adenoma, compact cell (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8372/0</td>
                    <td>Adrenal cortical adenoma, pigmented (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8373/0</td>
                    <td>Adrenal cortical adenoma, clear cell (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8374/0</td>
                    <td>Adrenal cortical adenoma, glomerulosa cell (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8375/0</td>
                    <td>Adrenal cortical adenoma, mixed cell (C74.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8380/0</td>
                    <td>Endometrioid adenoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8380/1</td>
                    <td>Endometrioid adenoma, borderline malignancy</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8380/3</td>
                    <td>Endometrioid adenocarcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8381/0</td>
                    <td>Endometrioid adenofibroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8381/1</td>
                    <td>Endometrioid adenofibroma, borderline malignancy</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8381/3</td>
                    <td>Endometrioid adenofibroma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8382/3</td>
                    <td>Endometrioid adenocarcinoma, secretory variant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8383/3</td>
                    <td>Endometrioid adenocarcinoma, ciliated cell variant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8384/3</td>
                    <td>Adenocarcinoma, endocervical type</td>
                    <td>ICD-O 3rd</td>
                    <td>ADENOMAS AND ADENOCARCINOMAS</td>
                </tr>
                <tr>
                    <td>8390/0</td>
                    <td>Skin appendage adenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8390/3</td>
                    <td>Skin appendage carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8391/0</td>
                    <td>Follicular fibroma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8392/0</td>
                    <td>Syringofibroadenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8400/0</td>
                    <td>Sweat gland adenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8400/1</td>
                    <td>Sweat gland tumor, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8400/3</td>
                    <td>Sweat gland adenocarcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8401/0</td>
                    <td>Apocrine adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8401/3</td>
                    <td>Apocrine adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8402/0</td>
                    <td>Nodular hidradenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8402/3</td>
                    <td>Nodular hidradenoma, malignant (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8403/0</td>
                    <td>Eccrine spiradenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8403/3</td>
                    <td>Malignant eccrine spiradenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8404/0</td>
                    <td>Hidrocystoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8405/0</td>
                    <td>Papillary hidradenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8406/0</td>
                    <td>Papillary syringadenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8407/0</td>
                    <td>Syringoma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8407/3</td>
                    <td>Sclerosing sweat duct carcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8408/0</td>
                    <td>Eccrine papillary adenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8408/1</td>
                    <td>Aggressive digital papillary adenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8408/3</td>
                    <td>Eccrine papillary adenocarcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8409/0</td>
                    <td>Eccrine poroma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8409/3</td>
                    <td>Eccrine poroma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8410/0</td>
                    <td>Sebaceous adenoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8410/3</td>
                    <td>Sebaceous adenocarcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8413/3</td>
                    <td>Eccrine adenocarcinoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8420/0</td>
                    <td>Ceruminous adenoma (C44.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8420/3</td>
                    <td>Ceruminous adenocarcinoma (C44.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>ADNEXAL AND SKIN APPENDAGE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8430/1</td>
                    <td>Mucoepidermoid tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>MUCOEPIDERMOID NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8430/3</td>
                    <td>Mucoepidermoid carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MUCOEPIDERMOID NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8440/0</td>
                    <td>Cystadenoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8440/3</td>
                    <td>Cystadenocarcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8441/0</td>
                    <td>Serous cystadenoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8441/3</td>
                    <td>Serous cystadenocarcinoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8442/1</td>
                    <td>Serous cystadenoma, borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8443/0</td>
                    <td>Clear cell cystadenoma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8444/1</td>
                    <td>Clear cell cystic tumor of borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8450/0</td>
                    <td>Papillary cystadenoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8450/3</td>
                    <td>Papillary cystadenocarcinoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8451/1</td>
                    <td>Papillary cystadenoma, borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8452/1</td>
                    <td>Solid pseudopapillary tumor (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8452/3</td>
                    <td>Solid pseudopapillary carcinoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8453/0</td>
                    <td>Intraductal papillary-mucinous adenoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8453/1</td>
                    <td>Intraductal papillary-mucinous tumor with moderate dysplasia (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8453/2</td>
                    <td>Intraductal papillary-mucinous carcinoma, non invasive (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8453/3</td>
                    <td>Intraductal papillary-mucinous carcinoma, invasive (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8454/0</td>
                    <td>Cystic tumor of atrio-ventricular node (C38._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8460/0</td>
                    <td>Papillary serous cystadenoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8460/3</td>
                    <td>Papillary serous cystadenocarcinoma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8461/0</td>
                    <td>Serous surface papilloma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8461/3</td>
                    <td>Serous surface papillary carcinoma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8462/1</td>
                    <td>Serous papillary cystic tumor of borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8463/1</td>
                    <td>Serous surface papillary tumor of borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8470/0</td>
                    <td>Mucinous cystadenoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8470/1</td>
                    <td>Mucinous cystic tumor with moderate dysplasia (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8470/2</td>
                    <td>Mucinous cystadenocarcinoma, non-invasive (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8470/3</td>
                    <td>Mucinous cystadenocarcinoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8471/0</td>
                    <td>Papillary mucinous cystadenoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8471/3</td>
                    <td>Papillary mucinous cystadenocarcinoma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8472/1</td>
                    <td>Mucinous cystic tumor of borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8473/1</td>
                    <td>Papillary mucinous cystadenoma, borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8480/0</td>
                    <td>Mucinous adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8480/3</td>
                    <td>Mucinous adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8480/6</td>
                    <td>Pseudomyxoma peritonei (C48.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8481/3</td>
                    <td>Mucin-producing adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8482/3</td>
                    <td>Mucinous adenocarcinoma, endocervical type</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8490/3</td>
                    <td>Signet ring cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8490/6</td>
                    <td>Metastatic signet ring cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>CYSTIC, MUCINOUS AND SEROUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8500/2</td>
                    <td>Intraductal carcinoma, noninfiltrating, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8500/3</td>
                    <td>Infiltrating duct carcinoma, NOS (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8501/2</td>
                    <td>Comedocarcinoma, noninfiltrating (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8501/3</td>
                    <td>Comedocarcinoma, NOS (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8502/3</td>
                    <td>Secretory carcinoma of breast (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8503/0</td>
                    <td>Intraductal papilloma</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8503/2</td>
                    <td>Noninfiltrating intraductal papillary adenocarcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8503/3</td>
                    <td>Intraductal papillary adenocarcinoma with invasion (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8504/0</td>
                    <td>Intracystic papillary adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8504/2</td>
                    <td>Noninfiltrating intracystic carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8504/3</td>
                    <td>Intracystic carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8505/0</td>
                    <td>Intraductal papillomatosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8506/0</td>
                    <td>Adenoma of nipple (C50.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8507/2</td>
                    <td>Intraductal micropapillary carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8508/3</td>
                    <td>Cystic hypersecretory carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8510/3</td>
                    <td>Medullary carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8512/3</td>
                    <td>Medullary carcinoma with lymphoid stroma</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8513/3</td>
                    <td>Atypical medullary carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8514/3</td>
                    <td>Duct carcinoma, desmoplastic type</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8520/2</td>
                    <td>Lobular carcinoma in situ. NOS (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8520/3</td>
                    <td>Lobular carcinoma, NOS (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8521/3</td>
                    <td>Infiltrating ductular carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8522/2</td>
                    <td>Intraductal carcinoma and lobular carcinoma in situ (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8522/3</td>
                    <td>Infiltrating duct and lobular carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8523/3</td>
                    <td>Infiltrating duct mixed with other types of carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8524/3</td>
                    <td>Infiltrating lobular mixed with other types of carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8525/3</td>
                    <td>Polymorphous low grade adenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8530/3</td>
                    <td>Inflammatory carcinoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8540/3</td>
                    <td>Paget's disease, mammary (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8541/3</td>
                    <td>Paget's disease and infiltrating duct carcinoma of breast (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8542/3</td>
                    <td>Paget's disease, extramammary (except Paget's disease of bone)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8543/3</td>
                    <td>Paget's disease and intraductal carcinoma of breast (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>DUCTAL AND LOBULAR NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8550/0</td>
                    <td>Acinar cell adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ACINAR CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8550/1</td>
                    <td>Acinar cell tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ACINAR CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8550/3</td>
                    <td>Acinar cell carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ACINAR CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8551/3</td>
                    <td>Acinar cell cystadenocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ACINAR CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8560/0</td>
                    <td>Mixed squamous cell and glandular pailloma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8560/3</td>
                    <td>Adenosquamous carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8561/0</td>
                    <td>Adenolymphoma (C07._, C08._)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8562/3</td>
                    <td>Epithelial-myoepithelial carcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8570/3</td>
                    <td>Adenocarcinoma with squamous metaplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8571/3</td>
                    <td>Adenocarcinoma with cartilaginous and osseous metaplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8572/3</td>
                    <td>Adenocarcinoma with spindle cell metaplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8573/3</td>
                    <td>Adenocarcinoma with apocrine metaplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8574/3</td>
                    <td>Adenocarcinoma with neuroendocrine differentiation</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8575/3</td>
                    <td>Metaplastic carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8576/3</td>
                    <td>Hepatoid adecarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8580/0</td>
                    <td>Thymoma, benign (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8580/1</td>
                    <td>Thymoma, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8580/3</td>
                    <td>Thymoma, malignant (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8581/1</td>
                    <td>Thymoma, type A, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8581/3</td>
                    <td>Thymoma, type A, malignant (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8582/1</td>
                    <td>Thymoma, type AB, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8582/3</td>
                    <td>Thymoma, type AB, malignant (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8583/1</td>
                    <td>Thymoma, type B1, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8583/3</td>
                    <td>Thymoma, type B1, malignant (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8584/1</td>
                    <td>Thymoma, type B2, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8584/3</td>
                    <td>Thymoma, type B2, malignant (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8585/1</td>
                    <td>Thymoma, type B3, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8585/3</td>
                    <td>Thymoma, type B3, malignant (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8586/3</td>
                    <td>Thymic carcinoma, NOS (C37.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8587/0</td>
                    <td>Ectopic hamartomatous thymoma</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8588/3</td>
                    <td>Spindle epithlial tumor with thymus-like element</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8589/3</td>
                    <td>Carcinoma showing thymus-like element</td>
                    <td>ICD-O 3rd</td>
                    <td>THYMIC EPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8590/1</td>
                    <td>Sex cord-gonadal stromal tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8591/1</td>
                    <td>Sex cord-gonadal stromal tumor, incompletely differentiated</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8592/1</td>
                    <td>Sex cord-gonadal stromal tumor, mixed forms</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8593/1</td>
                    <td>Stromal tumor with minor sex cord elements (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8600/0</td>
                    <td>Thecoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8600/3</td>
                    <td>Thecoma, malignant (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8601/0</td>
                    <td>Thecoma, luteinized (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8602/0</td>
                    <td>Sclerosing stromal tumor (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8610/0</td>
                    <td>Luteoma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8620/1</td>
                    <td>Granulosa cell tumor, adult type (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8620/3</td>
                    <td>Granulosa cell tumor, malignant (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8621/1</td>
                    <td>Granulosa cell-theca cell tumor (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8622/1</td>
                    <td>Granulosa cell tumor, juvenile (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8623/1</td>
                    <td>Sex cord tumor with annular tubules (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8630/0</td>
                    <td>Androblastoma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8630/1</td>
                    <td>Androblastoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8630/3</td>
                    <td>Androblastoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8631/0</td>
                    <td>Sertoli-Leydig cell tumor, well differentiated</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8631/1</td>
                    <td>Sertoli-Leydig cell tumor of intermediate differentiation</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8631/3</td>
                    <td>Sertoli-Leydig cell tumor, poorly differentiated</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8632/1</td>
                    <td>Gynandroblastoma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8633/1</td>
                    <td>Sertoli-Leydig cell tumor, retiform</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8634/1</td>
                    <td>Sertoli-Leydig cell tumor,intermediate differentiation, with heterologous elements</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8634/3</td>
                    <td>Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8640/0</td>
                    <td>Sertoli cell tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8640/3</td>
                    <td>Sertoli cell carcinoma (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8641/0</td>
                    <td>Sertoli cell tumor with lipid storage (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8642/1</td>
                    <td>Large cell calcifying Sertoli cell tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8650/0</td>
                    <td>Leydig cell tumor, benign (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8650/1</td>
                    <td>Leydig cell tumor, NOS (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8650/3</td>
                    <td>Leydig cell tumor, malignant (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8660/0</td>
                    <td>Hilus cell tumor (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8670/0</td>
                    <td>Lipid cell tumor of ovary (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8670/3</td>
                    <td>Steroid cell tumor, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8671/0</td>
                    <td>Adrenal rest tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>SPECIALIZED GONADAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8680/0</td>
                    <td>Paraganglioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8680/1</td>
                    <td>Paraganglioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8680/3</td>
                    <td>Paraganglioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8681/1</td>
                    <td>Sympathetic paraganglioma</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8682/1</td>
                    <td>Parasympathetic paraganglioma</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8683/0</td>
                    <td>Gangliocytic paraganglioma (C17.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8690/1</td>
                    <td>Glomus jugulare tumor, NOS (C75.5)</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8691/1</td>
                    <td>Aortic body tumor (C75.5)</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8692/1</td>
                    <td>Carotid body tumor (C75.4)</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8693/1</td>
                    <td>Extra-adrenal paraganglioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8693/3</td>
                    <td>Extra-adrenal paraganglioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8700/0</td>
                    <td>Pheochromocytoma, NOS (C74.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8700/3</td>
                    <td>Pheochromocytoma, malignant (C74.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8710/3</td>
                    <td>Glomangiosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8711/0</td>
                    <td>Glomus tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8711/3</td>
                    <td>Glomus tumor, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8712/0</td>
                    <td>Glomangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8713/0</td>
                    <td>Glomangiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>PARAGANGLIOMAS AND GLOMUS TUMORS</td>
                </tr>
                <tr>
                    <td>8720/0</td>
                    <td>Pigmented nevus, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8720/2</td>
                    <td>Melanoma in situ</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8720/3</td>
                    <td>Malignant melanoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8721/3</td>
                    <td>Nodular melanoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8722/0</td>
                    <td>Balloon cell nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8722/3</td>
                    <td>Balloon cell melanoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8723/0</td>
                    <td>Halo nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8723/3</td>
                    <td>Malignant melanoma, regressing (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8725/0</td>
                    <td>Neuronevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8726/0</td>
                    <td>Magnocellular nevus (C69.4)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8727/0</td>
                    <td>Dysplastic nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8728/0</td>
                    <td>Diffuse melanocytosis (C70.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8728/1</td>
                    <td>Meningeal melanocytoma (C70.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8728/3</td>
                    <td>Meningeal melanomatosis (C70.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8730/0</td>
                    <td>Nonpigmented nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8730/3</td>
                    <td>Amelanotic melanoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8740/0</td>
                    <td>Junctional nevus, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8740/3</td>
                    <td>Malignant melanoma in junctional nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8741/2</td>
                    <td>Precancerous melanosis, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8741/3</td>
                    <td>Malignant melanoma in precancerous melanosis (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8742/2</td>
                    <td>Lentigo maligna (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8742/3</td>
                    <td>Lentigo maligna melanoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8743/3</td>
                    <td>Superficial spreading melanoma (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8744/3</td>
                    <td>Acral lentiginous melanoma, malignant (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8745/3</td>
                    <td>Desmoplastic melanoma, malignant (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8746/3</td>
                    <td>Mucosal lentiginous melanoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8750/0</td>
                    <td>Intradermal nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8760/0</td>
                    <td>Compound nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8761/0</td>
                    <td>Small congenital nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8761/1</td>
                    <td>Giant pigmented nevus, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8761/3</td>
                    <td>Malignant melanoma in giant pigmented nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8762/1</td>
                    <td>Proliferative dermal lesion in congenital nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8770/0</td>
                    <td>Epithelioid and spindle cell nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8770/3</td>
                    <td>Mixed epithelioid and spindle cell melanoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8771/0</td>
                    <td>Epithelioid cell nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8771/3</td>
                    <td>Epithelioid cell melanoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8772/0</td>
                    <td>Spindle cell nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8772/3</td>
                    <td>Spindle cell melanoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8773/3</td>
                    <td>Spindle cell melanoma, type A (C69._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8774/3</td>
                    <td>Spindle cell melanoma, type B (C69._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8780/0</td>
                    <td>Blue nevus, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8780/3</td>
                    <td>Blue nevus, malignant (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8790/0</td>
                    <td>Cellular blue nevus (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEVI AND MELANOMAS</td>
                </tr>
                <tr>
                    <td>8800/0</td>
                    <td>Soft tissue tumor, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8800/3</td>
                    <td>Sarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8800/9</td>
                    <td>Sarcomatosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8801/3</td>
                    <td>Spindle cell sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8802/3</td>
                    <td>Giant cell sarcoma (except of Bone M-9250/3)</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8803/3</td>
                    <td>Small cell sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8804/3</td>
                    <td>Epithelioid sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8805/3</td>
                    <td>Undifferentiated sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8806/3</td>
                    <td>Desmoplastic small round cell tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>SOFT TISSUE TUMORS AND SARCOMAS, NOS</td>
                </tr>
                <tr>
                    <td>8810/0</td>
                    <td>Fibroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8810/1</td>
                    <td>Cellular fibroma (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8810/3</td>
                    <td>Fibrosarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8811/0</td>
                    <td>Fibromyxoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8811/3</td>
                    <td>Fibromyxosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8812/0</td>
                    <td>Periosteal fibroma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8812/3</td>
                    <td>Periosteal fibrosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8813/0</td>
                    <td>Fascial fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8813/3</td>
                    <td>Fascial fibrosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8814/3</td>
                    <td>Infantile fibrosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8815/0</td>
                    <td>Solitary fibrous tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8815/3</td>
                    <td>Solitary fibrous tumor, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8820/0</td>
                    <td>Elastofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8821/1</td>
                    <td>Aggressive fibromatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8822/1</td>
                    <td>Abdominal fibromatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8823/0</td>
                    <td>Desmoplastic fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8824/0</td>
                    <td>Myofriboma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8824/1</td>
                    <td>Myofibromatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8825/0</td>
                    <td>Myofibroblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8825/1</td>
                    <td>Myofibroblastic tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8826/0</td>
                    <td>Angiomyofibroblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8827/1</td>
                    <td>Myofibroblastic tumor, peribronchial (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8830/0</td>
                    <td>Benign fibrous histiocytoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8830/1</td>
                    <td>Atypical fibrous histiocytoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8830/3</td>
                    <td>Malignant fibrous histiocytoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8831/0</td>
                    <td>Histiocytoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8832/0</td>
                    <td>Dermatofibroma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8832/3</td>
                    <td>Dermatofibrosarcoma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8833/3</td>
                    <td>Pigmented dermatofibrosarcoma protuberans</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8834/1</td>
                    <td>Giant cell fibroblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8835/1</td>
                    <td>Plexiform fibrohistiocytic tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8836/1</td>
                    <td>Angiomatoid fibrous histiocytoma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8840/0</td>
                    <td>Myxoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYXOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8840/3</td>
                    <td>Myxosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYXOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8841/1</td>
                    <td>Angiomyxoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYXOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8842/0</td>
                    <td>Ossifying fibromyxoid tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>MYXOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8850/0</td>
                    <td>Lipoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8850/1</td>
                    <td>Atypical lipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8850/3</td>
                    <td>Liposarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8851/0</td>
                    <td>Fibrolipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8851/3</td>
                    <td>Liposarcoma, well differentiated</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8852/0</td>
                    <td>Fibromyxolipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8852/3</td>
                    <td>Myxoid liposarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8853/3</td>
                    <td>Round cell liposarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8854/0</td>
                    <td>Pleomorphic lipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8854/3</td>
                    <td>Pleomorphic liposarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8855/3</td>
                    <td>Mixed liposarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8856/0</td>
                    <td>Intramuscular lipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8857/0</td>
                    <td>Spindle cell lipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8857/3</td>
                    <td>Fibroblastic liposarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8858/3</td>
                    <td>Dedifferentiated liposarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8860/0</td>
                    <td>Angiomyolipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8861/0</td>
                    <td>Angiolipoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8862/0</td>
                    <td>Chondroid lipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8870/0</td>
                    <td>Myelolipoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8880/0</td>
                    <td>Hibernoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8881/0</td>
                    <td>Lipoblastomatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>LIPOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8890/0</td>
                    <td>Leiomyoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8890/1</td>
                    <td>Leiomyomatosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8890/3</td>
                    <td>Leiomyosarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8891/0</td>
                    <td>Epithelioid leiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8891/3</td>
                    <td>Epithelioid leiomyosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8892/0</td>
                    <td>Cellular leiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8893/0</td>
                    <td>Bizarre leiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8894/0</td>
                    <td>Angiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8894/3</td>
                    <td>Angiomyosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8895/0</td>
                    <td>Myoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8895/3</td>
                    <td>Myosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8896/3</td>
                    <td>Myxoid leiomyosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8897/1</td>
                    <td>Smooth muscle tumor of uncertain malignat potential</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8898/1</td>
                    <td>Metastasizing leiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8900/0</td>
                    <td>Rhabdomyoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8900/3</td>
                    <td>Rhabdomyosarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8901/3</td>
                    <td>Pleomorphic rhabdomyosarcoma, adult type</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8902/3</td>
                    <td>Mixed type rhabdomyosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8903/0</td>
                    <td>Fetal rhabdomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8904/0</td>
                    <td>Adult rhabdomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8905/0</td>
                    <td>Genital rhabdomyoma (C51._, C52.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8910/3</td>
                    <td>Embryonal rhabdomyosarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8912/3</td>
                    <td>Spindle cell rhabdomyosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8920/3</td>
                    <td>Alveolar rhabdomyosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8921/3</td>
                    <td>Rhabdomyosarcoma with ganglionic differentiation</td>
                    <td>ICD-O 3rd</td>
                    <td>MYOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8930/0</td>
                    <td>Endometrial stromal nodule (C54.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8930/3</td>
                    <td>Endometrial stromal sarcoma (C54.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8931/3</td>
                    <td>Endometrial stromal sarcoma, low grade (C54.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8932/0</td>
                    <td>Adenomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8933/3</td>
                    <td>Adenosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8934/3</td>
                    <td>Carcinofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8935/0</td>
                    <td>Stromal tumor, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8935/1</td>
                    <td>Stromal tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8935/3</td>
                    <td>Stromal sarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8936/0</td>
                    <td>Gastrointestinal stromal tumor, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8936/1</td>
                    <td>Gastrointestinal stromal tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8936/3</td>
                    <td>Gastrointestinal stromal sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8940/0</td>
                    <td>Pleomorphic adenoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8940/3</td>
                    <td>Mixed tumor, malignant, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8941/3</td>
                    <td>Carcinoma in pleomorphic adenoma (C07._, C08._)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8950/3</td>
                    <td>Mullerian mixed tumor (C54._)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8951/3</td>
                    <td>Mesodermal mixed tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8959/0</td>
                    <td>Benign cystic nephroma (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8959/1</td>
                    <td>Cystic partially differentiated nephroblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8959/3</td>
                    <td>Malignant cystic nephroma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8960/1</td>
                    <td>Mesoblastic nephroma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8960/3</td>
                    <td>Nephroblastoma, NOS (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8963/3</td>
                    <td>Malignant rhabdoid tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8964/3</td>
                    <td>Clear cell sarcoma of kidney (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8965/0</td>
                    <td>Nephrogenic adenofriboma (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8966/0</td>
                    <td>Renomedullary interstitial cell tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8967/0</td>
                    <td>Ossifying renal tumor (C64.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8970/3</td>
                    <td>Hepatoblastoma (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8971/3</td>
                    <td>Pancreatoblastoma (C25._)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8972/3</td>
                    <td>Pulmonary blastoma (C34._)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8973/3</td>
                    <td>Pleuropulmonary blastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8974/1</td>
                    <td>Sialoblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8980/3</td>
                    <td>Carcinosarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8981/3</td>
                    <td>Carcinosarcoma, embryonal</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8982/0</td>
                    <td>Myoepithelioma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8982/3</td>
                    <td>Malignant myoepithelioma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8983/0</td>
                    <td>Adenomyoepithelioma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8990/0</td>
                    <td>Mesenchymoma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8990/1</td>
                    <td>Mesenchymoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8990/3</td>
                    <td>Mesenchymoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>8991/3</td>
                    <td>Embryonal sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>COMPLEX MIXED AND STROMAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9000/0</td>
                    <td>Brenner tumor, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9000/1</td>
                    <td>Brenner tumor, borderline malignancy (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9000/3</td>
                    <td>Brenner tumor, malignant (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9010/0</td>
                    <td>Fibroadenoma, NOS (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9011/0</td>
                    <td>Intracanalicular fibroadenoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9012/0</td>
                    <td>Pericanalicular fibroadenoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9013/0</td>
                    <td>Adenofibroma, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9014/0</td>
                    <td>Serous adenofibroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9014/1</td>
                    <td>Serous adenofibroma of borderline malignancy</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9014/3</td>
                    <td>Serous adenocarcinofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9015/0</td>
                    <td>Mucinous adenofibroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9015/1</td>
                    <td>Mucinous adenofibroma of borderline malignancy</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9015/3</td>
                    <td>Mucinous Adenocarcinofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9016/0</td>
                    <td>Giant fibroadenoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9020/0</td>
                    <td>Phyllodes tumor, benign (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9020/1</td>
                    <td>Phyllodes tumor, borderline (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9020/3</td>
                    <td>Phyllodes tumor, malignant (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9030/0</td>
                    <td>Juvenile fibroadenoma (C50._)</td>
                    <td>ICD-O 3rd</td>
                    <td>FIBROEPITHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9040/0</td>
                    <td>Synovioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>SYNOVIAL-LIKE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9040/3</td>
                    <td>Synovial sarcoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>SYNOVIAL-LIKE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9041/3</td>
                    <td>Synovial sarcoma, spindle cell</td>
                    <td>ICD-O 3rd</td>
                    <td>SYNOVIAL-LIKE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9042/3</td>
                    <td>Synovial sarcoma, epithelioid cell</td>
                    <td>ICD-O 3rd</td>
                    <td>SYNOVIAL-LIKE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9043/3</td>
                    <td>Synovial sarcoma, biphasic</td>
                    <td>ICD-O 3rd</td>
                    <td>SYNOVIAL-LIKE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9044/3</td>
                    <td>Clear cell sarcoma, NOS (except of Kidney M-8964/3)</td>
                    <td>ICD-O 3rd</td>
                    <td>SYNOVIAL-LIKE NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9050/0</td>
                    <td>Mesothelioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9050/3</td>
                    <td>Mesothelioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9051/0</td>
                    <td>Fibrous mesothelioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9051/3</td>
                    <td>Fibrous mesothelioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9052/0</td>
                    <td>Epithelioid mesothelioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9052/3</td>
                    <td>Epithelioid mesothelioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9053/3</td>
                    <td>Mesothelioma, biphasic, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9054/0</td>
                    <td>Adenomatoid tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9055/0</td>
                    <td>Multicystic mesothelioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9055/1</td>
                    <td>Cystic mesothelioma, NOS (C48._)</td>
                    <td>ICD-O 3rd</td>
                    <td>MESOTHELIAL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9060/3</td>
                    <td>Dysgerminoma</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9061/3</td>
                    <td>Seminoma, NOS (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9062/3</td>
                    <td>Seminoma, anaplastic (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9063/3</td>
                    <td>Spermatocytic seminoma (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9064/2</td>
                    <td>Intratubular malignant germ cells (C64.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9064/3</td>
                    <td>Germinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9065/3</td>
                    <td>Germ cell tumor, nonseminomatous (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9070/3</td>
                    <td>Embryonal carcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9071/3</td>
                    <td>Yolk sac tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9072/3</td>
                    <td>Polyembryoma</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9073/1</td>
                    <td>Gonadoblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9080/0</td>
                    <td>Teratoma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9080/1</td>
                    <td>Teratoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9080/3</td>
                    <td>Teratoma, malignant, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9081/3</td>
                    <td>Teratocarcinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9082/3</td>
                    <td>Malignant teratoma, undifferentiated</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9083/3</td>
                    <td>Malignant teratoma, intermediate</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9084/0</td>
                    <td>Dermoid cyst, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9084/3</td>
                    <td>Teratoma with malignant transformation</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9085/3</td>
                    <td>Mixed germ cell tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9090/0</td>
                    <td>Struma ovarii, NOS (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9090/3</td>
                    <td>Struma ovarii, malignant (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9091/1</td>
                    <td>Strumal carcinoid (C56.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>GERM CELL NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9100/0</td>
                    <td>Hydatidiform mole, NOS (C58.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9100/1</td>
                    <td>Invasive hydatidiform mole (C58.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9100/3</td>
                    <td>Choriocarcinoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9101/3</td>
                    <td>Choriocarcinoma combined with other germ cell elements</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9102/3</td>
                    <td>Malignant teratoma, trophoblastic (C62._)</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9103/0</td>
                    <td>Partial hydatidiform mole (C58.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9104/1</td>
                    <td>Placental site trophoblastic tumor (C58.9)</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9105/3</td>
                    <td>Trophoblastic tumor, epithelioid</td>
                    <td>ICD-O 3rd</td>
                    <td>TROPHOBLASTIC NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9110/0</td>
                    <td>Mesonephroma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>MESONEPHROMAS</td>
                </tr>
                <tr>
                    <td>9110/1</td>
                    <td>Mesonephric tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MESONEPHROMAS</td>
                </tr>
                <tr>
                    <td>9110/3</td>
                    <td>Mesonephroma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>MESONEPHROMAS</td>
                </tr>
                <tr>
                    <td>9120/0</td>
                    <td>Hemangioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9120/3</td>
                    <td>Hemangiosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9121/0</td>
                    <td>Cavernous hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9122/0</td>
                    <td>Venous hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9123/0</td>
                    <td>Racemose hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9124/3</td>
                    <td>Kupffer cell sarcoma (C22.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9125/0</td>
                    <td>Epithelioid hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9130/0</td>
                    <td>Hemangioendothelioma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9130/1</td>
                    <td>Hemangioendothelioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9130/3</td>
                    <td>Hemangioendothelioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9131/0</td>
                    <td>Capillary hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9132/0</td>
                    <td>Intramuscular hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9133/1</td>
                    <td>Epithelioid hemangioendothelioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9133/3</td>
                    <td>Epithelioid hemangioendothelioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9135/1</td>
                    <td>Endovascular papillary angioendothelioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9136/1</td>
                    <td>Spindle cell hemangioendothelioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9140/3</td>
                    <td>Kaposi sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9141/0</td>
                    <td>Angiokeratoma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9142/0</td>
                    <td>Verrucous keratotic hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9150/0</td>
                    <td>Hemangiopericytoma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9150/1</td>
                    <td>Hemangiopericytoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9150/3</td>
                    <td>Hemangiopericytoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9160/0</td>
                    <td>Angiofibroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9161/0</td>
                    <td>Acquired tufted hemangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9161/1</td>
                    <td>Hemangioblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>BLOOD VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9170/0</td>
                    <td>Lymphangioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9170/3</td>
                    <td>Lymphangiosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9171/0</td>
                    <td>Capillary lymphangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9172/0</td>
                    <td>Cavernous lymphangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9173/0</td>
                    <td>Cystic lymphangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9174/0</td>
                    <td>Lymphangiomyoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9174/1</td>
                    <td>Lymphangiomyomatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9175/0</td>
                    <td>Hemolymphangioma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHATIC VESSEL TUMORS</td>
                </tr>
                <tr>
                    <td>9180/0</td>
                    <td>Osteoma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9180/3</td>
                    <td>Osteosarcoma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9181/3</td>
                    <td>Chondroblastic osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9182/3</td>
                    <td>Fibroblastic osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9183/3</td>
                    <td>Telangiectatic osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9184/3</td>
                    <td>Osteosarcoma in Paget's disease of bone (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9185/3</td>
                    <td>Small cell osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9186/3</td>
                    <td>Central osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9187/3</td>
                    <td>Intraosseous well differentiated osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9191/0</td>
                    <td>Osteoid osteoma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9192/3</td>
                    <td>Parosteal osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9193/3</td>
                    <td>Periosteal osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9194/3</td>
                    <td>High grade surface osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9195/3</td>
                    <td>Intracortical osteosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9200/0</td>
                    <td>Osteoblastoma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9200/1</td>
                    <td>Aggressive osteoblastoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9210/0</td>
                    <td>Osteochondroma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9210/1</td>
                    <td>Osteochondromatosis, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9220/0</td>
                    <td>Chondroma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9220/1</td>
                    <td>Chondromatosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9220/3</td>
                    <td>Chondrosarcoma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9221/0</td>
                    <td>Juxtacortical chondroma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9221/3</td>
                    <td>Juxtacortical chondrosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9230/0</td>
                    <td>Chondroblastoma, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9230/3</td>
                    <td>Chondroblastoma, malignant (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9231/3</td>
                    <td>Myxoid chondrosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9240/3</td>
                    <td>Mesenchymal chondrosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9241/0</td>
                    <td>Chondromyxoid fibroma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9242/3</td>
                    <td>Clear cell chondrosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9243/3</td>
                    <td>Dedifferentiated chondrosarcoma (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>OSSEOUS AND CHONDROMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9250/1</td>
                    <td>Giant cell tumor of bone, NOS (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GIANT CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9250/3</td>
                    <td>Giant cell tumor of bone, malignant (C40._, C41._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GIANT CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9251/1</td>
                    <td>Giant cell tumor of soft parts, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>GIANT CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9251/3</td>
                    <td>Malignant giant cell tumor of soft parts</td>
                    <td>ICD-O 3rd</td>
                    <td>GIANT CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9252/0</td>
                    <td>Tenosynovial giant cell tumor (C49._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GIANT CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9252/3</td>
                    <td>Malignant tenosynovial giant cell tumor (C49._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GIANT CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9260/3</td>
                    <td>Ewing sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS BONE TUMORS (C40._, C41._)</td>
                </tr>
                <tr>
                    <td>9261/3</td>
                    <td>Adamantinoma of long bones</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS BONE TUMORS (C40._, C41._)</td>
                </tr>
                <tr>
                    <td>9262/0</td>
                    <td>Ossifying fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS BONE TUMORS (C40._, C41._)</td>
                </tr>
                <tr>
                    <td>9270/0</td>
                    <td>Odontogenic tumor, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9270/1</td>
                    <td>Odontogenic tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9270/3</td>
                    <td>Odontogenic tumor, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9271/0</td>
                    <td>Ameloblastic fibrodentinoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9272/0</td>
                    <td>Cementoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9273/0</td>
                    <td>Cementoblastoma, benign</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9274/0</td>
                    <td>Cementifying fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9275/0</td>
                    <td>Gigantiform cementoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9280/0</td>
                    <td>Odontoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9281/0</td>
                    <td>Compound odontoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9282/0</td>
                    <td>Complex odontoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9290/0</td>
                    <td>Ameloblastic fibro-odontoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9290/3</td>
                    <td>Ameloblastic odontosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9300/0</td>
                    <td>Adenomatoid odontogenic tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9301/0</td>
                    <td>Calcifying odontogenic cyst</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9302/0</td>
                    <td>Odontogenic ghost cell tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9310/0</td>
                    <td>Ameloblastoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9310/3</td>
                    <td>Ameloblastoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9311/0</td>
                    <td>Odontoameloblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9312/0</td>
                    <td>Squamous odontogenic tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9320/0</td>
                    <td>Odontogenic myxoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9321/0</td>
                    <td>Central odontogenic fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9322/0</td>
                    <td>Peripheral odontogenic fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9330/0</td>
                    <td>Ameloblastic fibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9330/3</td>
                    <td>Ameloblastic fibrosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9340/0</td>
                    <td>Calcifying epithelial odontogenic tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9341/1</td>
                    <td>Clear cell odontogenic tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9342/3</td>
                    <td>Odontogenic carcinosarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>ODONTOGENIC TUMORS (C41._)</td>
                </tr>
                <tr>
                    <td>9350/1</td>
                    <td>Craniopharyngioma (C75.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9351/1</td>
                    <td>Craniopharyngioma, adamantinomatous (C75.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9352/1</td>
                    <td>Craniopharyngioma, papillary (C75.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9360/1</td>
                    <td>Pinealoma (C75.3)</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9361/1</td>
                    <td>Pineocytoma (C75.3)</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9362/3</td>
                    <td>Pineoblastoma (C75.3)</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9363/0</td>
                    <td>Melanotic neuroectodermal tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9364/3</td>
                    <td>Peripheral neuroectodermal tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9365/3</td>
                    <td>Askin tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9370/3</td>
                    <td>Chordoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9371/3</td>
                    <td>Chondroid chordoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9372/3</td>
                    <td>Dedifferentiated chordoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9373/0</td>
                    <td>Parachordoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MISCELLANEOUS TUMORS</td>
                </tr>
                <tr>
                    <td>9380/3</td>
                    <td>Glioma, malignant (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9381/3</td>
                    <td>Gliomatosis cerebri (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9382/3</td>
                    <td>Mixed glioma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9383/1</td>
                    <td>Subependymoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9384/1</td>
                    <td>Subependymal giant cell astrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9390/0</td>
                    <td>Choroid plexus papilloma, NOS (C71.5)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9390/1</td>
                    <td>Atypical choroid plexus papilloma (C71.5)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9390/3</td>
                    <td>Choroid plexus carcinoma (C71.5)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9391/3</td>
                    <td>Ependymoma, NOS (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9392/3</td>
                    <td>Ependymoma, anaplastic (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9393/1</td>
                    <td>Papillary ependymoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9394/1</td>
                    <td>Myxopapillary ependymoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9400/3</td>
                    <td>Astrocytoma, NOS (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9401/3</td>
                    <td>Astrocytoma, anaplastic (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9410/3</td>
                    <td>Protoplasmic astrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9411/3</td>
                    <td>Gemistocytic astrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9412/1</td>
                    <td>Desmoplastic infantile astrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9413/0</td>
                    <td>Dysembryoplastic neuroepithelial tumor (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9420/3</td>
                    <td>Fibrillary astrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9421/1</td>
                    <td>Pilocytic astrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9423/3</td>
                    <td>Polar spongioblastoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9424/3</td>
                    <td>Pleomorphic xanthoastrocytoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9430/3</td>
                    <td>Astroblastoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9440/3</td>
                    <td>Glioblastoma, NOS (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9441/3</td>
                    <td>Giant cell glioblastoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9442/1</td>
                    <td>Gliofibroma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9442/3</td>
                    <td>Gliosarcoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9444/1</td>
                    <td>Chordoid glioma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9450/3</td>
                    <td>Oligodendroglioma, NOS (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9451/3</td>
                    <td>Oligodendroglioma, anaplastic (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9460/3</td>
                    <td>Oligodendroblastoma (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9470/3</td>
                    <td>Medulloblastoma, NOS (C71.6)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9471/3</td>
                    <td>Desmoplastic nodular medulloblastoma (C71.6)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9472/3</td>
                    <td>Medullomyoblastoma (C71.6)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9473/3</td>
                    <td>Primitive neuroectodermal tumor, NOS (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9474/3</td>
                    <td>Large cell medulloblastoma (C71.6)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9480/3</td>
                    <td>Cerebellar sarcoma, NOS (C71.6)</td>
                    <td>ICD-O 3rd</td>
                    <td>GLIOMAS</td>
                </tr>
                <tr>
                    <td>9490/0</td>
                    <td>Ganglioneuroma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9490/3</td>
                    <td>Ganglioneuroblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9491/0</td>
                    <td>Ganglioneuromatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9492/0</td>
                    <td>Gangliocytoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9493/0</td>
                    <td>Dysplastic gangliocytoma of cerebellum (C71.6)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9500/3</td>
                    <td>Neuroblastoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9501/0</td>
                    <td>Medulloepithelioma, benign (C69.4)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9501/3</td>
                    <td>Medulloepithelioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9502/0</td>
                    <td>Teratoid medulloepithelioma, benign (C69.4)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9502/3</td>
                    <td>Teratoid medulloepithelioma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9503/3</td>
                    <td>Neuroepithelioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9504/3</td>
                    <td>Spongioneuroblastoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9505/1</td>
                    <td>Ganglioglioma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9505/3</td>
                    <td>Ganglioma, anaplastic</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9506/1</td>
                    <td>Central neurocytoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9507/0</td>
                    <td>Pacinian tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9508/3</td>
                    <td>Atypical teratoid/rhabdoid tumor (C71._)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9510/0</td>
                    <td>Retinocytoma (C69.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9510/3</td>
                    <td>Retinoblastoma, NOS (C69.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9511/3</td>
                    <td>Retinoblastoma, differentiated (C69.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9512/3</td>
                    <td>Retinoblastoma, undifferentiated (C69.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9513/3</td>
                    <td>Retinoblastoma, diffuse (C69.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9514/1</td>
                    <td>Retinoblastoma, spontaneously regressed (C69.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9520/3</td>
                    <td>Olfactory neurogenic tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9521/3</td>
                    <td>Olfactory neurocytoma (C30.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9522/3</td>
                    <td>Olfactory neuroblastoma (C30.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9523/3</td>
                    <td>Olfactory neuroepithelioma (C30.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>NEUROEPITHELIOMATOUS NEOPLASMS</td>
                </tr>
                <tr>
                    <td>9530/0</td>
                    <td>Meningioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9530/1</td>
                    <td>Meningiomatosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9530/3</td>
                    <td>Meningioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9531/0</td>
                    <td>Meningothelial meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9532/0</td>
                    <td>Fibrous meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9533/0</td>
                    <td>Psammomatous meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9534/0</td>
                    <td>Angiomatous meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9535/0</td>
                    <td>Hemangioblastic meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9537/0</td>
                    <td>Transitional meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9538/1</td>
                    <td>Clear cell meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9538/3</td>
                    <td>Papillary meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9539/1</td>
                    <td>Atypical meningioma</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9539/3</td>
                    <td>Meningeal sarcomatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>MENINGIOMAS (C70._)</td>
                </tr>
                <tr>
                    <td>9540/0</td>
                    <td>Neurofibroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9540/1</td>
                    <td>Neurofibromatosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9540/3</td>
                    <td>Malignant peripheral nerve sheath tumor</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9541/0</td>
                    <td>Melanotic neurofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9550/0</td>
                    <td>Plexiform neurofibroma</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9560/0</td>
                    <td>Neurilemoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9560/1</td>
                    <td>Neurinomatosis</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9560/3</td>
                    <td>Neurilemoma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9561/3</td>
                    <td>Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9562/0</td>
                    <td>Neurothekeoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9570/0</td>
                    <td>Neuroma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9571/0</td>
                    <td>Perineurioma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9571/3</td>
                    <td>Perineurioma, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>NERVE SHEATH TUMORS</td>
                </tr>
                <tr>
                    <td>9580/0</td>
                    <td>Granular cell tumor, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>GRANULAR CELL TUMORS AND ALVEOLAR SOFT PART SARCOMA</td>
                </tr>
                <tr>
                    <td>9580/3</td>
                    <td>Granular cell tumor, malignant</td>
                    <td>ICD-O 3rd</td>
                    <td>GRANULAR CELL TUMORS AND ALVEOLAR SOFT PART SARCOMA</td>
                </tr>
                <tr>
                    <td>9581/3</td>
                    <td>Alveolar soft part sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>GRANULAR CELL TUMORS AND ALVEOLAR SOFT PART SARCOMA</td>
                </tr>
                <tr>
                    <td>9582/0</td>
                    <td>Granular cell tumor of the sellar region (C75.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>GRANULAR CELL TUMORS AND ALVEOLAR SOFT PART SARCOMA</td>
                </tr>
                <tr>
                    <td>9590/3</td>
                    <td>Malignant lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MALIGNANT LYMPHOMA, NOS, OR DIFFUSE</td>
                </tr>
                <tr>
                    <td>9591/3</td>
                    <td>Malignant lymphoma, non-Hodgkin, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MALIGNANT LYMPHOMA, NOS, OR DIFFUSE</td>
                </tr>
                <tr>
                    <td>9596/3</td>
                    <td>Composite Hodgkin and non-Hodgkin lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MALIGNANT LYMPHOMA, NOS, OR DIFFUSE</td>
                </tr>
                <tr>
                    <td>9650/3</td>
                    <td>Hodgkin lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9651/3</td>
                    <td>Hodgkin lymphoma, lymphocyte-rich</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9652/3</td>
                    <td>Hodgkin lymphoma, mixed cellularity, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9653/3</td>
                    <td>Hodgkin lymphoma, lymphocytic depletion, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9654/3</td>
                    <td>Hodgkin lymphoma, lymphocytic depletion, diffuse fibrosis</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9655/3</td>
                    <td>Hodgkin lymphoma, lymphocytic depletion, reticular</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9659/3</td>
                    <td>Hodgkin lymphoma, lymphocytic predominance, nodular</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9661/3</td>
                    <td>Hodgkin granuloma</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9662/3</td>
                    <td>Hodgkin sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9663/3</td>
                    <td>Hodgkin lymphoma, nodular sclerosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9664/3</td>
                    <td>Hodgkin lymphoma, nodular sclerosis, cellular phase</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9665/3</td>
                    <td>Hodgkin lymphoma, nodular sclerosis, grade 1</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9667/3</td>
                    <td>Hodgkin lymphoma, nodular sclerosis, grade 2</td>
                    <td>ICD-O 3rd</td>
                    <td>HODGKIN LYMPHOMA</td>
                </tr>
                <tr>
                    <td>9670/3</td>
                    <td>Malignant lymphoma, small B lymphocytic, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9671/3</td>
                    <td>Malignant lymphoma, lymphoplasmacytic</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9673/3</td>
                    <td>Mantle cell lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9675/3</td>
                    <td>Malignant lymphoma, mixed small and large cell, diffuse</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9678/3</td>
                    <td>Primary effusion lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9679/3</td>
                    <td>Mediastinal large B-cell lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9680/3</td>
                    <td>Malignant lymphoma, large B-cell, diffuse, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9684/3</td>
                    <td>Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9687/3</td>
                    <td>Burkitt lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9689/3</td>
                    <td>Splenic marginal zone-B-cell lymphoma (C42.2)</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9690/3</td>
                    <td>Follicular lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9691/3</td>
                    <td>Follicular lymphoma, grade 2</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9695/3</td>
                    <td>Follicular lymphoma, grade 1</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9698/3</td>
                    <td>Follicular lymphoma, grade 3</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9699/3</td>
                    <td>Marginal zone B-cell lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE B-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9700/3</td>
                    <td>Mycosis fungoides (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9701/3</td>
                    <td>Sezary syndrome</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9702/3</td>
                    <td>Mature T-cell lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9705/3</td>
                    <td>Angioimmunoblastic T-cell lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9708/3</td>
                    <td>Subcutaneous panniculitis-like-T-cell lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9709/3</td>
                    <td>Cutaneous T-cell lymphoma, NOS (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9714/3</td>
                    <td>Anaplastic large cell lymphoma, T cell and null cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9716/3</td>
                    <td>Hepatosplenic (gamma-delta) cell lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9717/3</td>
                    <td>Intestinal T-cell lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9718/3</td>
                    <td>Lymphomatoid papulosis (C44._)</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9719/3</td>
                    <td>NK/T-cell lymphoma, nasal and nasal-type</td>
                    <td>ICD-O 3rd</td>
                    <td>MATURE T- AND NK-CELL LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9727/3</td>
                    <td>Precursor cell lymphoblastic lymphoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>PRECURSOR CELL LYMPHOBLASTIC LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9728/3</td>
                    <td>Precursor B-cell lymphoblastic lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>PRECURSOR CELL LYMPHOBLASTIC LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9729/3</td>
                    <td>Precursor T-cell lymphoblastic lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>PRECURSOR CELL LYMPHOBLASTIC LYMPHOMAS</td>
                </tr>
                <tr>
                    <td>9731/3</td>
                    <td>Plasmacytoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>PLASMA CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9732/3</td>
                    <td>Multiple myeloma (C42.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>PLASMA CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9733/3</td>
                    <td>Plasma cell leukemia (C42.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>PLASMA CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9734/3</td>
                    <td>Plasmacytoma, extramedullary</td>
                    <td>ICD-O 3rd</td>
                    <td>PLASMA CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9740/1</td>
                    <td>Mastocytoma, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MAST CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9740/3</td>
                    <td>Mast cell sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MAST CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9741/3</td>
                    <td>Malignant mastocytosis</td>
                    <td>ICD-O 3rd</td>
                    <td>MAST CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9742/3</td>
                    <td>Mast cell leukemia (C42.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>MAST CELL TUMORS</td>
                </tr>
                <tr>
                    <td>9750/3</td>
                    <td>Malignant histiocytosis</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9751/1</td>
                    <td>Langerhans cell histiocytosis, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9752/1</td>
                    <td>Langerhans cell histiocytosis, unifocal</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9753/1</td>
                    <td>Langerhans cell histiocytosis, multifocal</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9754/3</td>
                    <td>Langerhans cell histiocytosis, disseminated</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9755/3</td>
                    <td>Histiocytic sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9756/3</td>
                    <td>Langerhans cell sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9757/3</td>
                    <td>Interdigitating dendritic cell sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9758/3</td>
                    <td>Follicular dendritic cell sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS</td>
                </tr>
                <tr>
                    <td>9760/3</td>
                    <td>Immunoproliferative disease, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9761/3</td>
                    <td>Waldenstrom macroglobulinemia (C42.0)</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9762/3</td>
                    <td>Heavy chain disease, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9764/3</td>
                    <td>Immunoproliferative small intestinal disease (C17._)</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9765/1</td>
                    <td>Monoclonal gammopathy of undetermined significance</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9766/1</td>
                    <td>Angiocentric immunoproliferative lesion</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9767/1</td>
                    <td>Angioimmunoblastic lymphadenopathy</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9768/1</td>
                    <td>T-gamma lymphoproliferative disease</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9769/1</td>
                    <td>Immunoglobulin deposition disease</td>
                    <td>ICD-O 3rd</td>
                    <td>IMMUNOPROLIFERATIVE DISEASES</td>
                </tr>
                <tr>
                    <td>9800/3</td>
                    <td>Leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LEUKEMIAS, NOS (C42.1)</td>
                </tr>
                <tr>
                    <td>9801/3</td>
                    <td>Acute leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LEUKEMIAS, NOS (C42.1)</td>
                </tr>
                <tr>
                    <td>9805/3</td>
                    <td>Acute biphenotypic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>LEUKEMIAS, NOS (C42.1)</td>
                </tr>
                <tr>
                    <td>9820/3</td>
                    <td>Lymphoid leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9823/3</td>
                    <td>B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9826/3</td>
                    <td>Burkitt cell leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9827/3</td>
                    <td>Adult T-cell leukemia/lymphoma (HTLV-1 positive)</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9831/3</td>
                    <td>T-cell large granular lymphocytic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9832/3</td>
                    <td>Prolymphocytic leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9833/3</td>
                    <td>Prolymphocytic leukemia, B-cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9834/3</td>
                    <td>Prolymphocytic leukemia, T-cell type</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9835/3</td>
                    <td>Precursor cell lymphoblastic leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9836/3</td>
                    <td>Precursor B-cell lymphoblastic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9837/3</td>
                    <td>Precursor T-cell lymphoblastic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>LYMPHOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9840/3</td>
                    <td>Acute myeloid leukemia, M6 type</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9860/3</td>
                    <td>Myeloid leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9861/3</td>
                    <td>Acute myeloid leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9863/3</td>
                    <td>Chronic myeloid leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9866/3</td>
                    <td>Acute promyelocytic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9867/3</td>
                    <td>Acute myelomonocytic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9870/3</td>
                    <td>Acute basophilic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9871/3</td>
                    <td>Acute myeloid leukemia with abnormal marrow eosinophils</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9872/3</td>
                    <td>Acute myeloid leukemia, minimal differentiation</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9873/3</td>
                    <td>Acute myeloid leukemia without maturation</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9874/3</td>
                    <td>Acute myeloid leukemia with maturation</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9875/3</td>
                    <td>Chronic myelogenous leukemia, BCR/ABL positive</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9876/3</td>
                    <td>Atypical chronic myeloid leukemia, BCR/ABL negative</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9891/3</td>
                    <td>Acute monocytic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9895/3</td>
                    <td>Acute myeloid leukemia with multilineage dysplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9896/3</td>
                    <td>Acute myeloid leukemia, t(8;21)(q22;q22)</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9897/3</td>
                    <td>Acute myeloid leukemia, 11q23 adnormalities</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9910/3</td>
                    <td>Acute megakaryoblastic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9920/3</td>
                    <td>Therapy-related acute myeloid leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9930/3</td>
                    <td>Myeloid sarcoma</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9931/3</td>
                    <td>Acute panmyelosis with myelofibrosis (C42.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELOID LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9940/3</td>
                    <td>Hairy cell leukemia (C42.1)</td>
                    <td>ICD-O 3rd</td>
                    <td>OTHER LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9945/3</td>
                    <td>Chronic myelomonocytic leukemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>OTHER LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9946/3</td>
                    <td>Juvenile myelomonocytic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>OTHER LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9948/3</td>
                    <td>Aggressive NK-cell leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>OTHER LEUKEMIAS (C42.1)</td>
                </tr>
                <tr>
                    <td>9950/3</td>
                    <td>Polycythemia vera</td>
                    <td>ICD-O 3rd</td>
                    <td>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</td>
                </tr>
                <tr>
                    <td>9960/3</td>
                    <td>Chronic myeloproliferative disease, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</td>
                </tr>
                <tr>
                    <td>9961/3</td>
                    <td>Myelosclerosis with myeloid metaplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</td>
                </tr>
                <tr>
                    <td>9962/3</td>
                    <td>Essential thrombocythemia</td>
                    <td>ICD-O 3rd</td>
                    <td>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</td>
                </tr>
                <tr>
                    <td>9963/3</td>
                    <td>Chronic neutrophilic leukemia</td>
                    <td>ICD-O 3rd</td>
                    <td>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</td>
                </tr>
                <tr>
                    <td>9964/3</td>
                    <td>Hypereosinophilic syndrome</td>
                    <td>ICD-O 3rd</td>
                    <td>CHRONIC MYELOPROLIFERATIVE DISORDERS (C42.1)</td>
                </tr>
                <tr>
                    <td>9970/1</td>
                    <td>Lymphoproliferative disorder, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>OTHER HEMATOLOGIC DISORDERS</td>
                </tr>
                <tr>
                    <td>9975/1</td>
                    <td>Myeloproliferative disease, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>OTHER HEMATOLOGIC DISORDERS</td>
                </tr>
                <tr>
                    <td>9980/3</td>
                    <td>Refractory anemia, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9982/3</td>
                    <td>Refractory anemia with sideroblasts</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9983/3</td>
                    <td>Refractory anemia with excess blasts</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9984/3</td>
                    <td>Refractory anemia with excess blasts in transformation</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9985/3</td>
                    <td>Refractory cytopenia with multilineage dysplasia</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9986/3</td>
                    <td>Myelodysplastic syndrome with 5q deletion</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9987/3</td>
                    <td>Therapy-related myelodysplastic syndrome</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                <tr>
                    <td>9989/3</td>
                    <td>Myelodysplastic syndrome, NOS</td>
                    <td>ICD-O 3rd</td>
                    <td>MYELODYSPLASTIC SYNDROMES (C42.1)</td>
                </tr>
                </tbody>
            </table>
        </div>
    </div>
</main>
{% endblock %}
